The World Anti-Doping Agency on Tuesday suspended the UCLA Olympic Analytical Laboratory’s accreditation to test for certain anabolic steroids and glucocorticoids.
The three-month suspension follows a quality assessment of the UCLA lab by WADA that determined the Los Angeles lab that “identified non-conformities with best practice.”
“The Agency’s procedures focus on consistent analysis being carried out by WADA-accredited laboratories in order to ensure comparable, valid and reliable results; which, in turn, is intended to give athletes greater confidence and trust in the global anti-doping system,” WADA said in a statement.
The UCLA lab began testing for the U.S. Olympic Committee in 1985 and then the U.S. Anti-Doping Agency in 2000. The lab also conducts test for the NCAA and NFL and ran testing for the 1984, 1996 and 2002 Olympic Games and 1994 World Cup.
More than 40 scientists perform examine 45,000 specimens each year.
During the three-month suspension the UCLA lab will still be able to test for some banned substances.
“It is important to note that, during the suspension, the UCLA Laboratory can continue carrying out all its regular anti-doping activities,” WADA said. “However, the Laboratory must obtain a second opinion from another WADA-accredited laboratory prior to reporting any Adverse Analytical Finding (AAF) for the glucocorticoids ‘prednisolone’ and ‘prednisone’; and, the anabolic steroids ‘boldenone’ and ‘boldione.’
“This type of suspension, which is limited to certain substances or classes of substances and that has been applied to other WADA-accredited laboratories in the past, allows for appropriate monitoring of the UCLA Laboratory to ensure full implementation of necessary improvements with the objective of return to full compliance.”